SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.
SwipeRx has raised $10.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.
SwipeRx's investors include Bill & Melinda Gates Foundation, Sanofi, 500 Global, Endeavor Catalyst, MDI Ventures.
SwipeRx is headquartered in Singapore, Singapore.
SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.
SwipeRx is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SwipeRx — Funding & Investors." VCBacked, February 9, 2023, https://www.vcbacked.co/company/swiperx. Accessed July 19, 2026.
VCBacked. (2023). SwipeRx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/swiperx
{{cite web |title=SwipeRx — Funding & Investors |url=https://www.vcbacked.co/company/swiperx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated